Technology in Cancer Research & Treatment
Overview
Technology in Cancer Research & Treatment is a peer-reviewed journal that focuses on the latest advancements in technology and its applications in cancer research and treatment. It covers a wide range of topics including imaging techniques, molecular diagnostics, targeted therapies, bioinformatics, and nanotechnology. The journal provides a platform for researchers, clinicians, and engineers to share their innovative approaches and discoveries, ultimately contributing to the improvement of cancer diagnosis, prognosis, and therapy.
Details
Details
Abbr.
Technol Cancer Res Treat
Start
2002
End
Continuing
Frequency
Bimonthly
p-ISSN
1533-0346
e-ISSN
1533-0338
Country
United States
Language
English
Specialties
Oncology
Pharmacology
Biomedical Engineering
Pharmacology
Biomedical Engineering
Metrics
Metrics
h-index / Ranks: 4950
72
SJR / Ranks: 7389
609
CiteScore / Ranks: 6169
4.30
JIF / Ranks: 3791
2.8
Recent Articles
11.
Chen Q, Hao Q, Yang Y, Li L, Li D, Zhao R, et al.
Technol Cancer Res Treat
. 2025 Feb;
24:15330338251319144.
PMID: 39912257
Background: Carboxylesterase 4A (CES4A) belongs to the member of the carboxylesterase family, yet there has been limited research into its malignant biological behavior in malignant tumors. Here, we aim to...
12.
Topkan E, Somay E, Selek U
Technol Cancer Res Treat
. 2025 Feb;
24:15330338241305823.
PMID: 39902806
We congratulate Lang and colleagues for their study investigating the impact of resection margin (RM) size on locoregional control (LC) outcomes, overall survival (OS), progression-free survival (PFS), and treatment-related toxicity...
13.
Dosanjh M, Degiovanni A, Necchi M, Benedetto E
Technol Cancer Res Treat
. 2025 Feb;
24:15330338241311859.
PMID: 39895029
The battle against cancer remains a top priority for society, with an urgent need to develop therapies capable of targeting challenging tumours while preserving patient's quality of life. Hadron Therapy...
14.
Ma J, Ma X, Zhang W, Hu S, Zang R, Wu X, et al.
Technol Cancer Res Treat
. 2025 Jan;
24:15330338251317571.
PMID: 39887207
Background: Small cell lung cancer is sensitive to chemotherapy and radiotherapy, but local recurrence and distant metastasis occur shortly after treatment. This study aimed to evaluate the real-world value of...
15.
Alfreahat I, Nsairat H, Aldeeb I, Al-Samydai A, Alshaer W
Technol Cancer Res Treat
. 2025 Jan;
24:15330338241312561.
PMID: 39865928
Background: Doxorubicin (DOX) is a potent chemotherapeutic agent for breast cancer, but its effectiveness is often diminished by resistance mechanisms, particularly through p-glycoprotein (P-gp) mediated drug efflux. Clarithromycin (CAM), a...
16.
Yanes R, Saridogan T, Gorantla V, Overacre A, Hsieh R, Celebrezze J, et al.
Technol Cancer Res Treat
. 2025 Jan;
24:15330338251317094.
PMID: 39865921
The management of early-stage colon cancer involves surgical resection of the primary tumor with or without chemotherapy, depending on pathological staging. The benefit of adjuvant chemotherapy for stage II and...
17.
Huang S, Li B, Chen H, Rong C, Yang Z, Zhang X
Technol Cancer Res Treat
. 2025 Jan;
24:15330338251315625.
PMID: 39865876
Long non-coding RNAs (lncRNAs) are known to play vital roles in human cancers. LncRNA TRPM2-AS has been found to be upregulated in various types of cancers. The elevated levels of...
18.
Allegra A, Nicosia L, Rigo M, Bianchi N, Borgese R, Simone A, et al.
Technol Cancer Res Treat
. 2025 Jan;
24:15330338241297231.
PMID: 39865869
MR-guided radiotherapy (MRgRT) is novel treatment modality in Radiation Oncology that could allow a higher precision and tolerability of Radiation Treatments. This modality is possible due to dedicated systems consisting...
19.
Cai J, Peng X, Lu J
Technol Cancer Res Treat
. 2025 Jan;
24():15330338241311136.
PMID: 39840692
Purpose: To evaluate the impact of patient setup errors on the dosimetry and radiobiological models of intensity-modulated radiotherapy (IMRT) for esophageal cancer. Methods And Materials: This retrospective study with 56...
20.
Efficacy Analysis of Hypofractionated Radiotherapy for Oligometastatic Tumors: A Retrospective Study
Sun Q, Zhao H, Zhang X, Zhang S, He Z, Wang G, et al.
Technol Cancer Res Treat
. 2025 Jan;
24():15330338241310155.
PMID: 39819190
Introduction: Metastasis remains a major cause of death among patients with malignant tumors. Radiotherapy is one of the main modalities of cancer treatment. The rapid development of radiotherapy technology has...